Final answer:
The study on cyclosporine levels that resulted in missing data for one control and two patients requires investigation of the omissions and possibly repeating the tests. If this is not feasible, the missing data should be duly noted and possibly excluded from analysis, with the ramifications discussed in the study's findings.
Step-by-step explanation:
The question involves a scenario in which three controls and ten patients were part of a study measuring the levels of cyclosporine, a drug that suppresses immune rejection in organ transplants by inhibiting the production of interleukin. When results are missing from the printout for one control and two patients, the appropriate action is to investigate the reason for these omissions. Proper experimental procedure requires that every participant's results are accounted for to ensure the validity and reliability of the study. If the missing results are due to error or instrument malfunction, the tests for those subjects need to be repeated.
If repeating the tests is not possible, the data for these subjects may need to be excluded from the analysis, and the potential implications of their absence should be discussed when presenting the study's findings. Clear documentation and protocol adherence, especially when dealing with clinical test results, are essential in maintaining the integrity of a study and ensuring that any conclusions drawn are based on complete and accurate data.